UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy

Gut, 2004-10, Vol.53 (10), p.1504-1508

2004

Volltextzugriff (PDF)

New therapies for the treatment of chronic hepatitis C

Current pharmaceutical design, 2002-01, Vol.8 (11), p.959

2002

Volltextzugriff (PDF)

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials

Gastroenterology (New York, N.Y. 1943), 1999-08, Vol.117 (2), p.408-413

1999

Volltextzugriff (PDF)

Ribavirin and interferon-α combination therapy vs interferon-α alone in the retreatment of chronic hepatitis C: a randomized clinical trial

Journal of viral hepatitis, 1997-05, Vol.4 (3), p.185-192

1997

Volltextzugriff (PDF)

Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?

Journal of hepatology, 1999, Vol.30 (1), p.8-13

1999

Volltextzugriff (PDF)

IFN alfa-con 1 + ribavirin combination therapy in naive difficult-to-treat patients affected by chronic hepatitis C

Journal of hepatology, 2001-04, Vol.34, p.147-148

Bellobuono, A

2001

Volltextzugriff (PDF)

Comparison between IFN induction therapy, IFN induction + ribavirin and IFN + ribavirin standard combination therapy in naive patients with chronic hepatitis C related to genotype 1: final report

Journal of hepatology, 2001-04, Vol.34, p.148

Bellobuono, A

2001

Volltextzugriff (PDF)

Interferon-ribavirin combination therapy for chronic hepatitis C

Digestive diseases and sciences, 1996-12, Vol.41 (12), p.131S-134S

1996

Volltextzugriff (PDF)

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centers

Journal of hepatology, 1997-05, Vol.26 (5), p.961-966

1997

Volltextzugriff (PDF)

Comparison between fixed and escalating doses of alpha interferon treatment in chronic hepatitis C

Hepatology (Baltimore, Md.), 1995-10, Vol.22 (4), p.A152-A152

1995

Volltextzugriff (PDF)

Ferritin serum level may be a predictive factor of response to interferon treatment in chronic hepatitis C

Hepatology (Baltimore, Md.), 1993-10, Vol.18 (4), p.A223-A223

1993

Volltextzugriff (PDF)

Alpha interferon treatment in chronic hepatitis C

Clinical and experimental rheumatology, 1995-11, Vol.13 Suppl 13, p.S167

1995

Volltextzugriff (PDF)

Infectivity of blood that is immunoblot intermediate reactive on hepatitis C virus antibody testing

The Lancet (British edition), 1990-08, Vol.336 (8710), p.309-309

1990

Volltextzugriff (PDF)

Prevalence of Hepatitis C Virus Antibodies in Italian Blood Donors

Vox sanguinis, 1990-07, Vol.59 (1), p.26-29

1990

Volltextzugriff (PDF)

HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey

Journal of viral hepatitis, 2007-09, Vol.14 (9), p.618-623

2007

Volltextzugriff (PDF)

Anti-hepatitis C virus in blood donors with raised ALT levels

Transfusion (Philadelphia, Pa.), 1990-05, Vol.30 (4), p.382-382

1990

Volltextzugriff (PDF)

Antibodies to hepatitis C virus in Italian blood donors

The Lancet (British edition), 1989-09, Vol.2 (8666), p.797-797

1989

Volltextzugriff (PDF)

Prospective evaluation of posttransfusion hepatitis

Transfusion (Philadelphia, Pa.), 1991-05, Vol.31 (4), p.299-302

1991

Volltextzugriff (PDF)

Look-back at blood donors implicated in posttransfusion hepatitis (PTH)

Transfusion (Philadelphia, Pa.), 1991-01, Vol.31 (1), p.88-88

1991

Volltextzugriff (PDF)

ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN BLOOD DONORS

The Lancet (British edition), 1989-09, Vol.334 (8666), p.797-797

1989

Volltextzugriff (PDF)

Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy

Journal of hepatology, 2000-09, Vol.33 (3), p.463-468

2000

Volltextzugriff (PDF)

Molecular epidemiology of hepatitis C virus infection among intravenous drug users

Journal of hepatology, 1995-06, Vol.22 (6), p.691-695

1995

Volltextzugriff (PDF)

The aetiology of chronic hepatitis in Italy: results from a multicentre national study

Digestive and liver disease, 2004-12, Vol.36 (12), p.829-833

2004

Volltextzugriff (PDF)

Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study

European journal of gastroenterology & hepatology, 1999-11, Vol.11 (11), p.1203-1208

1999

Volltextzugriff (PDF)

Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6 999 cases

Journal of viral hepatitis, 2006-05, Vol.13 (5), p.351-354

2006

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy

New therapies for the treatment of chronic hepatitis C

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials

Ribavirin and interferon-α combination therapy vs interferon-α alone in the retreatment of chronic hepatitis C: a randomized clinical trial

Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?

IFN alfa-con 1 + ribavirin combination therapy in naive difficult-to-treat patients affected by chronic hepatitis C

Comparison between IFN induction therapy, IFN induction + ribavirin and IFN + ribavirin standard combination therapy in naive patients with chronic hepatitis C related to genotype 1: final report

Interferon-ribavirin combination therapy for chronic hepatitis C

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centers

Comparison between fixed and escalating doses of alpha interferon treatment in chronic hepatitis C

Ferritin serum level may be a predictive factor of response to interferon treatment in chronic hepatitis C

Alpha interferon treatment in chronic hepatitis C

Infectivity of blood that is immunoblot intermediate reactive on hepatitis C virus antibody testing

Prevalence of Hepatitis C Virus Antibodies in Italian Blood Donors

HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey

Anti-hepatitis C virus in blood donors with raised ALT levels

Antibodies to hepatitis C virus in Italian blood donors

Prospective evaluation of posttransfusion hepatitis

Look-back at blood donors implicated in posttransfusion hepatitis (PTH)

ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN BLOOD DONORS

Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy

Molecular epidemiology of hepatitis C virus infection among intravenous drug users

The aetiology of chronic hepatitis in Italy: results from a multicentre national study

Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study

Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6 999 cases

Suchergebnisse filtern